Health Care

Vertex insider sells 4,500 shares in routine plan‑based trade; market stays bullish on VRTX’s pipeline and earnings outlook.

CEO sells 5,466 Monte Rosa shares at $23.88: liquidity or confidence? Insider trades reveal no major downside, but highlight ongoing capital‑raising plans.

Garipalli Vivek’s latest Clover Health share purchase signals insider confidence, revealing why top shareholders buy during vesting and what it means for investors.

Butterfly Network CFO’s 60k‑share sell‑to‑cover at $3.98 shows a routine tax‑cover move, not a warning; investors can see it as normal liquidity and still focus on the company’s growth.

MoonLake CFO’s zero‑cost purchase of 354k restricted shares signals strong insider confidence amid a 2,800% social‑media buzz and an upcoming FDA‑approved BLA, hinting at potential upside for long‑term investors.

CEO Siokas Grigorios’s latest buy at Cosmos Health shows bullish confidence while a debt‑to‑equity swap strengthens the balance sheet—what’s next for the stock?

Insider confidence fuels bullish outlook for Mettler‑Toledo: CEO buys boost, stable holdings, and strong growth signals.

Insider buying at Nkarta signals confidence in its biotech pipeline—President Mahmood Nadir and execs are staking options on a $2.74 peak, hinting at future upside.

Zoetis insider buying signals leadership confidence and hints at future growth opportunities in animal‑health markets.

Insider buying fuels optimism for Erasca, as Garner Ebun buys shares under a Rule 10b5‑1 plan and exercises options, showing confidence in the company’s oncology pipeline and potential upside.